Clinical Cancer Research

Clinical Cancer Research

临床癌症研究

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Clinical Cancer Research》是由American Association for Cancer Research Inc.出版社于1995年创办的英文国际期刊(ISSN: 1078-0432,E-ISSN: 1557-3265),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.0195...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比88.84%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在457篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Cancer Research审稿周期约为约2.1月。该刊近年未被列入国际预警名单,年发文量约457篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 457 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
2区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 33 / 333

90.2

学科:ONCOLOGY SCIE Q1 25 / 333

92.64

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 29 / 328

91.3

学科:ONCOLOGY SCIE Q1 22 / 328

93.45

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 27 / 322

91.8

学科:ONCOLOGY SCIE Q1 18 / 322

94.57

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:17.3 SJR:4.751 SNIP:2.1
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 24 / 428

94%

大类:Medicine 小类:Cancer Research Q1 18 / 233

92%

期刊发文

  • Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Tria

    Author: Xue, Liqiong; Han, Yaqian; Zhang, Qingyuan; Li, Xia; Fang, Meiyu; Zhong, Laiping; Wang, Siyang; Liu, Yanyan; Zhang, Songnan; Li, Zhiming; Guo, Ye

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1445-1453. DOI: 10.1158/1078-0432.CCR-25-3930

  • Noninvasive Imaging Assessment of Tertiary Lymphoid Structures and Immunotherapy Response in Gastric Cancer: A Multicenter Stud

    Author: Sun, Zepang; Li, Zhenhui; Ahmad, M. Usman; Zhu, Yun; Zhou, Zixia; Zhou, Kangneng; Wu, Lin; Chen, Chuanli; Yuan, Qingyu; Zhang, Taojun; Chen, Yan; Xie, Jingjing; Feng, Wanying; Xu, Yikai; Xiong, Wenjun; Wang, Wei; Li, Guoxin; Jiang, Yuming

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 8, pp. 1486-1498. DOI: 10.1158/1078-0432.CCR-25-3669

  • Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherap

    Author: Shen, Yu; Wei, Mingtian; He, Yazhou; Yang, Tinghan; Deng, Xiangbing; Wu, Qingbin; Chen, Haining; Fan, Rui; Liu, Yiqian; Li, Qingyun; Li, Feifei; Gu, Xiafei; Lu, Zijian; Qiu, Meng; Meng, Wenjian; Jiang, Dan; Wang, Ziqiang

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1293-1301. DOI: 10.1158/1078-0432.CCR-25-3774

  • Redefining Treatment Paradigms for Glioma in Adolescents and Young Adults: Population-Based Evidence for Molecular Classificatio

    Author: Qu, Shanqiang; Pan, Qiuming; Zhang, Xin; Wang, Junxi; Li, Hongrui; Huang, Yudi; Liao, Kuilin; Ye, Zhi; Ainiwan, Yilamujiang; Yi, Guozhong; Li, Zhiyong; Liu, Junlu; Hou, Xiaomin; Xu, Haiyan; Chen, Zhuoyang; Mei, Fen; Liu, Tao; Zhang, Xi'an; Qi, Songtao; Huang, Guanglong

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1349-1361. DOI: 10.1158/1078-0432.CCR-25-2496

  • RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-623

    Author: Pfeil, Alexander J.; Zhang, Tom; Cheng, Ryan; Mattar, Marissa S.; Gomez Marti, Juan Luis; Gili, Leo; Lai, Rachel; Khodos, Inna; Master, Rohan P.; Dix, Jenna-Marie; Gazzo, Andrea; Arbour, Kathryn C.; de Stanchina, Elisa; Febres-Aldana, Christopher A.; Ladanyi, Marc; Yang, Soo-Ryum; Somwar, Romel

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1362-1375. DOI: 10.1158/1078-0432.CCR-25-2734

  • Clinical Significance for Risk Stratification of Papillary Thyroid Cancer by TUMORFISHER Circulating Tumor Cell Techniqu

    Author: Jiang, Liehao; Li, Xuejie; Ma, Tianyi; Zeng, Pingping; Tan, Zhuo; Zheng, Chuanming; Xu, Jiajie; Zhang, Lizhuo; Guo, Yaweng; Liang, Juyong; Pan, Yan; Teng, Weidong; Tao, Zekai; He, Jiantong; Yu, Haolan; Wang, Jiafeng; Hu, Zhiyuan; Ge, Minghua

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 7, pp. 1313-1324. DOI: 10.1158/1078-0432.CCR-25-2694

  • Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortiu

    Author: Waliany, Sarah; Cooper, Alissa J.; Liu, Stephen V.; Gautschi, Oliver; Rotow, Julia K.; Smith, Katherine Emilie Rhoades; Weber, Urs M.; Lee, Dae Ho; Loong, Herbert H. F.; Patel, Jyoti D.; Pennell, Nathan A.; Nagasaka, Misako; Patel, Shetal A.; Tan, Daniel S. W.; Solomon, Benjamin J.; Kim, Tae Min; Pall, Georg; Riess, Jonathan W.; Sun, Lova; Fruh, Martin; Uy, Natalie F.; Gadgeel, Shirish; Feng, Jamie; Do, Andrew; Falcon, Christina; Leighl, Natasha B.; Baik, Christina S.; Lai, Gillianne G. Y.; Ou, S. Ignatius; Cheung, Kingsley S. Y.; Patil, Tejas; Mansfield, Aaron S.; Weiler, Daniela; Yeap, Beow Y.; Wirth, Lori J.; Gainor, Justin F.; Drilon, Alexander; Lin, Jessica J

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1157-1168. DOI: 10.1158/1078-0432.CCR-25-4382

  • INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinom

    Author: Rischin, Danny; Hansen, Aaron R.; Cohen, Ezra E. W.; Tahara, Makoto; Harrington, Kevin J.; Haddad, Robert I.; Licitra, Lisa; Mehanna, Hisham; Ferris, Robert L.; Koralewski, Piotr; Penkov, Konstantin; Schenker, Michael; Spigel, David R.; Daste, Amaury; Hong, Min Hee; Guo, Ye; Chisamore, Michael J.; Washburn, Michael L.; Phillips-jones, Amy; Russell, John; Roy-ghanta, Sumita; Ellis, Catherine; Ballas, Marc; Le Tourneau, Christophe

    Journal: CLINICAL CANCER RESEARCH. 2026; Vol. 32, Issue 6, pp. 1087-1099. DOI: 10.1158/1078-0432.CCR-25-1197